Evidera
Pooja Sudarsan is a skilled medical writer currently employed at Evidera since March 2023, specializing in medical information. Prior to this role, Pooja held the position of Associate Scientific Writer at Indegene from September 2020 to March 2023, focusing on the development and review of unsolicited medical information requests from healthcare professionals. Pooja's experience also includes serving as a Clinical Pharmacist at Government Headquarters Hospital, Udhagamandalam, from June 2017 to June 2020, where responsibilities included monitoring drug-related problems across various clinical rotations. Additional clinical pharmacist experience was gained at G.Kuppuswamy Naidu Memorial Hospital and ASTER MEDCITY through rotations in oncology as well as urology, gynecology, and intensive care units. Pooja earned a Doctor of Pharmacy (PharmD) degree from JSS University in Mysore, completing the program in 2020.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.